APPLICATION OF ANALYTICAL HIERARCHY PROCESS FOR COMPARING VORTIOXETINE TO AGOMELATINE AND VENLAFAXINE XR IN MAJOR DEPRESSIVE DISORDER

被引：0
|
作者：
Briquet, B. [1 ]
Diamand, F. [2 ]
Francois, C. [3 ]
Brignone, M. [4 ]
机构：
[1] Benjamin BRIQUET, Levoncourt, France
[2] Lundbeck SAS, Paris, France
[3] Lundbeck, Deerfield, IL USA
[4] Lundbeck SAS, Issy Les Moulineaux, France
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH8
引用
收藏
页码：A292 / A292
页数：1
相关论文
共 50 条
  • [1] COST-UTILITY ANALYSIS EVALUATING VORTIOXETINE VERSUS VENLAFAXINE XR AND AGOMELATINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN TAIWAN
    Brignone, M.
    Atsou, K.
    Reynaud-Mougin, C.
    Chen, W.
    Milea, D.
    VALUE IN HEALTH, 2016, 19 (07) : A841 - A842
  • [2] Antidepressant for major depressive disorder. Comparison with vortioxetine, agomelatine, desvenlafaxine and bupropion XR
    Plasencia Garcia de Diego, B. O.
    Romero Guillena, S. L.
    Navarro Pablo, R.
    Gotor Sanchez-Luengo, F.
    Santamaria Gomez, O.
    EUROPEAN PSYCHIATRY, 2018, 48 : S205 - S206
  • [3] Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder A Pilot Study
    Martinotti, Giovanni
    Sepede, Gianna
    Gambi, Francesco
    Di Iorio, Giuseppe
    De Berardis, Domenico
    Di Nicola, Marco
    Onofrj, Marco
    Janiri, Luigi
    Di Giannantonio, Massimo
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (04) : 487 - 491
  • [4] Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland
    Soini, Erkki
    Hallinen, Taru
    Brignone, Melanie
    Campbell, Rosanne
    Diamand, Francoise
    Cure, Sandrine
    Aalto-Setala, Maria
    Danchenko, Natalya
    Koponen, Hannu
    Kolasa, Katarzyna
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (03) : 293 - 302
  • [5] COST-UTILITY OF VORTIOXETINE VERSUS VENLAFAXINE XR IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN SOUTH KOREA
    Jung, R.
    Brignone, M.
    Campbell, R.
    Franois, C.
    Milea, D.
    VALUE IN HEALTH, 2015, 18 (03) : A121 - A122
  • [6] Sertraline versus venlafaxine XR in major depressive disorder
    Lusicic, Ana
    Jagadheesan, Karuppiah
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (10) : 1618 - 1619
  • [7] COST-UTILITY OF VORTIOXETINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER: COMPARISON WITH AGOMELATINE, BUPROPION, SERTRALINE AND VENLAFAXINE IN THE FINNISH SETTING
    Soini, E. J.
    Hallinen, T.
    Brignone, M.
    Despiegel, N.
    Aalto-Setala, M.
    Danchenko, N.
    Kolasa, K.
    VALUE IN HEALTH, 2014, 17 (07) : A459 - A459
  • [8] A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder
    Montgomery, SA
    Huusom, AKT
    Bothmer, J
    NEUROPSYCHOBIOLOGY, 2004, 50 (01) : 57 - 64
  • [9] Venlafaxine XR versus escitalopram treatment of major depressive disorder
    Zarra, J
    Schmidt, L
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S394 - S395
  • [10] Escitalopram vs venlafaxine XR treatment of major depressive disorder
    Montgomery, SA
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S207 - S207
12345